Skip to content

Management of Childhood bronchial Asthma in Ayurveda

Efficacy of Drakshaharitakyadi Leha and Shirishadi Arka nebulization in the management of Tamaka Shwasa (asthma) in children - A single armed open labelled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051645
Enrollment
30
Registered
2023-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children, irrespective of gender belonging to age group of 6 to 16 years 2.Patient presenting with 3 minimum classical symptoms of Tamaka Shwasa ie Ghurghuraka Krichachrashaknoti bhasitum Asino Labhate Saukhyam Paarshva cha peedyan Kasa Peenas and Annadwishta 3.Patients having history of at least 2 episodes of acute asthma attacks which requires nebulization or inhaler of bronchodilator drugs during last month

Exclusion criteria

Exclusion criteria: 1.Evidence of requirement of intubations for Asthma or had been hospitalized for asthma within one month before Unresolved sinus disease or an unresolved Upper or Lower respiratory tract infection within 4 weeks 2.Known case of systemic illnesses such as TB, HIV and other chronic debilitating diseases. 3.Known case of active pulmonary disease other than asthma

Design outcomes

Primary

MeasureTime frame
1.AEC (absolute eosinophil count) 2.PRAM (Pediatric respiratory assessment measure) Anexure-2 3.PEFR (Peak expiratory flow rate) Timepoint: 8 weeks

Secondary

MeasureTime frame
• Improvement in Tamaka Shwasa symptoms i.e Shwasakrichhrata, Ghurghurukam, Kasa, Pinasa, ParshvaShula, KaphaNishthivana, Asino Labhate Saukhyam, Kanthodhwansa, Sleshma Vimokshante Labhate Sukham, Anidra, Ushnabhinanditi (0, 56th day) Anexure-3 • Total frequency of the acute episodes of asthma during last two months (0, 56th day) • Spirometer (FEV1) (0, 56th day) • ACT (Asthma control test) (0, 56th day) Anexure-1 • Breath holding time (0, 56th day) Timepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Sagar M Bhinde

Institute of Teaching and Research in Ayurveda Jamnagar

sgrbhinde@gmail.com9662512158

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026